Acadian Asset Management
BEAM icon

Acadian Asset Management’s Beam Therapeutics BEAM Stock Holding History

Acadian Asset Management’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$308K Buy
8,993
+5,645
+169% +$170K ﹤0.01% 1559
2026
Q1 		$79K Buy
+3,348
New +$92.9K ﹤0.01% 1797

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Acadian Asset Management's BEAM Position: Q2 2026 in Review

Acadian Asset Management increased its Beam Therapeutics (BEAM) stake by 169% in Q2 2026, buying an estimated $170K and bringing the position to 8,993 shares worth $308K. The position accounts for ﹤0.01% of the portfolio, ranked #1559.

Acadian Asset Management first reported a position in BEAM in Q1 2026 and has held it in 2 quarters since. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Acadian Asset Management held 8,993 shares of Beam Therapeutics worth $308K as of Q2 2026.
  • Acadian Asset Management bought 5,645 Beam Therapeutics shares in Q2 2026, an estimated $170K.
  • Beam Therapeutics made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1559 holding.
  • Acadian Asset Management first reported a position in Beam Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.